SOON-SHIONG PATRICK

CIK 000118902012 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001189020

Recent Transactions

50 trades

Tax Payment
ImmunityBio, Inc.$IBRX
Common Stock
2026-02-22$8.70/sh−58,170→ 29,757,911 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2026-02-22+114,329→ 29,816,081 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2026-02-22−114,329→ 114,329 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2026-02-10+274,122→ 29,820,312 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2026-02-10−274,122→ 548,246 total
Tax Payment
ImmunityBio, Inc.$IBRX
Common Stock
2026-02-10$6.93/sh−118,560→ 29,701,752 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2025-02-22+114,329→ 29,588,261 total
Tax Payment
ImmunityBio, Inc.$IBRX
Common Stock
2025-02-22$3.42/sh−42,071→ 29,546,190 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2025-02-22−114,329→ 228,658 total
Award
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2025-02-10+822,368→ 822,368 total
Award
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2025-02-10+2,812,500→ 2,812,500 total
Other
ImmunityBio, Inc.$IBRX
Second Amended and Restated Convertible Promissory Note
2024-12-10$505000000.00/sh
Other
ImmunityBio, Inc.$IBRX
Amended and Restated Promissory Note
2024-12-10
Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2024-12-10$1.94/sh+103,710,088→ 232,937,105 total
Conversion
ImmunityBio, Inc.$IBRX
Convertible Promissory Note
2024-12-10
Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2024-12-10$2.28/sh+13,475,172→ 246,412,277 total
Conversion
ImmunityBio, Inc.$IBRX
Convertible Promissory Note
2024-12-10
Award
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2024-02-22+1,193,597→ 1,193,597 total
Award
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2024-02-22+342,987→ 342,987 total
Other
ImmunityBio, Inc.$IBRX
Amended and Restated Promissory Note
2023-12-29$380000000.00/sh
Other
ImmunityBio, Inc.$IBRX
Convertible Promissory Note
2023-12-29$30000000.00/sh
Other
ImmunityBio, Inc.$IBRX
Common Stock
2023-09-11$1.29/sh+129,127,017→ 129,227,017 total
Other
ImmunityBio, Inc.$IBRX
Amended and Restated Convertible Promissory Note
2023-09-11
Other
ImmunityBio, Inc.$IBRX
Common Stock
2023-09-11$1.29/sh+47,557,934→ 47,557,934 total
Other
ImmunityBio, Inc.$IBRX
Second Amended and Restated Convertible Promissory Note
2023-09-11
Other
ImmunityBio, Inc.$IBRX
Second Amended and Restated Convertible Promissory Note
2023-09-11
Other
ImmunityBio, Inc.$IBRX
Amended and Restated Convertible Promissory Note
2023-09-11
Other
ImmunityBio, Inc.$IBRX
Common Stock
2023-09-11$1.29/sh+32,606,985→ 32,606,985 total
Purchase
ImmunityBio, Inc.$IBRX
Convertible Promissory Note
2023-09-11$200000000.00/sh
Other
ImmunityBio, Inc.$IBRX
Second Amended and Restated Convertible Promissory Note
2023-09-11
Purchase
NantHealth, Inc.
Common Stock
2023-08-28$0.39/sh+15,384,616→ 15,384,616 total
Purchase
NantHealth, Inc.
Common Stock
2023-08-28$18.61/sh+537,272→ 15,921,888 total
Purchase
ImmunityBio, Inc.$IBRX
Convertible Promissory Note
2023-05-12$30445859.00/sh
Conversion
ImmunityBio, Inc.$IBRX
Second Amended and Restated Convertible Promissory Note
2022-12-12
Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2022-12-12$5.67/sh+9,986,920→ 9,986,920 total
Purchase
ImmunityBio, Inc.$IBRX
Second Amended and Restated Convertible Promissory Note
2022-08-31$40016261.00/sh
Purchase
ImmunityBio, Inc.$IBRX
Amended and Restated Convertible Promissory Note
2022-08-31$55927342.00/sh
Purchase
ImmunityBio, Inc.$IBRX
Second Amended and Restated Convertible Promissory Note
2022-08-31$59524425.00/sh
Purchase
ImmunityBio, Inc.$IBRX
Second Amended and Restated Convertible Promissory Note
2022-08-31$55844638.00/sh
Purchase
ImmunityBio, Inc.$IBRX
Amended and Restated Convertible Promissory Note
2022-08-31$40407671.00/sh
Purchase
ImmunityBio, Inc.$IBRX
Second Amended and Restated Convertible Promissory Note
2022-08-31$63375911.00/sh
Award
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2022-03-23+350,000→ 350,000 total
Award
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2022-03-23+350,000→ 350,000 total
Award
NantHealth, Inc.
Stock Option (right to buy)
2021-09-09+1,000,000→ 1,000,000 total
Award
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2021-06-10+26,064→ 26,064 total
Purchase
NantHealth, Inc.
4.50% Convertible Senior Notes due 2026
2021-04-27$62500000.00/sh+62,500,000
Purchase
NantHealth, Inc.
Common Stock
2021-04-13$2.96/sh+1,689,189→ 1,689,189 total
Other
NantHealth, Inc.
5.50% Convertible Senior Notes due 2021
2021-04-13$5000000.00/sh−5,000,000→ 5,000,000 total
Other
ImmunityBio, Inc.$IBRX
Common Stock
2021-03-09+8,383,414→ 8,383,414 total
Other
ImmunityBio, Inc.$IBRX
Common Stock
2021-03-09+5,723,182→ 29,473,932 total

Companies

Recent Filings

Address

C/O IMMUNITYBIO, INC. 3530 JOHN HOPKINS COURT

SAN DIEGO, CA, 92121

View on SEC.gov